Scarica l'app Stockscreener
1.18
4.42%
0.05
Pre-mercato:
1.22
0.04
+3.39%
Entera Bio Ltd Borsa (ENTX) Ultime notizie
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613 - marketscreener.com
Entera Bio to Host Key Opinion Leader Webinar Highlighting - GlobeNewswire
Bear Alert: Should I invest in Entera Bio Ltd before earnings2026 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Entera Bio raises $10M in private placement led by BVF Partners - Investing.com Australia
Greenberg Traurig Represents Entera Bio in $10M Private Placement - National Today
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners - Finansavisen
Market Leaders: Is Entera Bio Ltd stock risky to hold now2026 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn
Entera Bio Ltd. Announces Private Placement and Securities Purchase Agreement for Phase 3 Osteoporosis Study Funding - Minichart
ENTX Technical Analysis & Stock Price Forecast - Intellectia AI
Entera Bio Announces $10 Million Private Placement Financing - TipRanks
Entera Bio Raises $10 Million in Private Placement With BVF Partners, Adds Registration Rights - TradingView — Track All Markets
Entera Bio (NASDAQ: ENTX) completes private placement with BVF funds - Stock Titan
Entera Bio submits streamlined Phase 3 protocol for oral osteoporosis drug - Investing.com
Fresh $10M gives Entera Bio runway for Phase 3 osteoporosis study - Stock Titan
Entera Bio Ltd. announced that it expects to receive $10 million in funding - marketscreener.com
Net current asset value per share of Entera Bio Ltd. – LS:A2JQXP - TradingView
Stock market today: S&P 500, Dow futures gain as Trump calls Iran's new leaders 'very reasonable'—Palantir, Rezolve AI, Entera Bio in focus - MSN
Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'— PLTR, RZLV, ENTX In Focus (UPDATED) - Benzinga
Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable' - Benzinga
Stock Market Today: S&P 500, Dow Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'—Palantir, Rezolve AI, Entera Bio In FocusState Street SPDR S&P 500 ETF Trust (ARCA:SPY) - Benzinga
Entera Bio Ltd. Advances First-in-Class Oral Peptide Therapies for Osteoporosis, Hypoparathyroidism, and Metabolic Diseases – 2026 Annual Report Highlights - Minichart
Entera Bio Reports $18.7 Million Net Loss for 2025 and $1.2 Million in Revenue - geneonline.com
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline - TipRanks
Entera Bio (NASDAQ:ENTX) Releases Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
ENTX: FDA-aligned EB613 Phase 3, pipeline advanced, net loss $11.4M, cash supports into Q3 2026 - TradingView
Entera 10-K: Revenue $0.042M, Loss Per Share $0.25 - TradingView
Entera Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Entera Bio (NASDAQ: ENTX) outlines oral osteoporosis and metabolic pipeline - Stock Titan
Entera Bio Ltd. Advances Oral Peptide Pipeline with Key FDA Submissions and Clinical Program Updates for Osteoporosis and Other Conditions - Quiver Quantitative
Entera Bio (NASDAQ: ENTX) 2025 loss widens as oral peptide pipeline advances - Stock Titan
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates - Bitget
Entera Bio Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com
S P Trends: Should I invest in Entera Bio Ltd before earnings2026 AllTime Highs & Capital Protection Trade Alerts - baoquankhu1.vn
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market - The Globe and Mail
Entera May Be the 1st Winner of FDA's New Framework Redefining the Multi Billion Dollar Osteoporosis Market - Benzinga
If You Invested $1,000 in Entera Bio Ltd (ENTX) - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
What pushed Entera Bio (ENTX) to rally nearly 16% after hours - MSN
Entera Bio (ENTX) Expected to Announce Earnings on Friday - marketbeat.com
Analyst Upgrade: Is Entera Bio Ltd stock risky to hold now2026 Winners & Losers & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Trend Review: Should I invest in Entera Bio Ltd before earnings2026 Spike Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
Energy Moves: Can Entera Bio Ltd weather a recession2026 Opening Moves & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Entera Takes Final Step Towards Phase 3, Accelerating Timeline f - GuruFocus
Performance Recap: Is Entera Bio Ltd stock risky to hold now2026 Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy - TipRanks
Entera Bio (NASDAQ:ENTX) Director Geno Germano Purchases 20,000 Shares - MarketBeat
Insider Buying: Geno Germano Acquires Additional Shares of Enter - GuruFocus
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):